BioAtla Inc

NASDAQ:BCAB  
1.62
-0.08 (-4.71%)
6:07:33 PM EDT: $1.62 0.00 (0.00%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

BioAtla Inc Stock, NASDAQ:BCAB

11085 Torreyana Road, San Diego, California 92121
United States of America
Phone: +1.858.558.0708
Number of Employees: 65
http://www.BioAtla.com

Description

BioAtla, Inc. engages in the development of novel class of specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its CAB portfolio include MABs & ADCS, BA3011, and BA3021. The company was founded by Jay M. Short and Carolyn Anderson in March 2007 and is headquartered in San Diego, CA.